Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total Therapy for Infants With ALL I
NCT02553460Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jan 2016
- Primary completion
- May 2022
- Modality
- Modified Peptides, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bortezomib, vorinostat in acute lymphoblastic leukemia (ALL), sponsored by St. Jude Children's Research Hospital. Started Jan 2016; status: active, not recruiting.
02
Drugs
bortezomibvorinostat
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02553460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02553460.